Impact of the soluble interleukin-2 receptor level in the relapsed or refractory phase on the clinical outcome of patients with diffuse large B-cell lymphoma

Kento UminoDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan

Shin-Ichiro FujiwaraDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan

Takashi IkedaDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan

Shin-Ichiro KawaguchiDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan

Yumiko TodaDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan

Shoko ItoDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan

Shin-Ichi OchiDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan

Takashi NagayamaDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan

Kiyomi MashimaDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan

Daisuke MinakataDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan

Hirofumi NakanoDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan

Ryoko YamasakiDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan

Kaoru MoritaDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan

Yasufumi KawasakiDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan

Chihiro YamamotoDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan

Masahiro AshizawaDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan

Kaoru HatanoDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan

Kazuya SatoDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan

Iekuni OhDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan

Ken OhmineDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan

Kazuo MuroiDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan

Yoshinobu KandaDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, JapanCorrespondence[email protected]

Your download is now in progress and you may close this window